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ABSTRACT
Introduction
Multimorbidity, commonly defined as having two or more chronic conditions, is a major
burden in middle-aged and older adults, causing increased risks for hospitalizations,
medical care costs, and even death. One condition with severe adverse effects in the
older population is depression. Depression has been shown to increase ones social
isolation while compounding self-management, eventually increasing ones chance for
mortality. Multimorbidity coupled with depression has been shown to increase the risk
for mortality; however, these results are typically based on a one-time depression
evaluation. The main objective of this study is to examine if depressive symptom
trajectories modifies the effect multimorbidity has on all-cause and cause-specific
(cancer and cardiovascular disease) mortality.
Methods
Data obtained from the Health and Retirement Study (HRS) was used for this study. A
multimorbidity variable was created using data from the 2004 wave of the HRS. Three
distinct depressive symptom trajectories were created using the biennial waves from
1998, 2000, 2002, and 2004 (persistently low, persistently moderate, and persistently
high). Deaths were analyzed and categorized from the 2006, 2008, 2010, 2012, and 2014
datasets. Confounders were analyzed in 2004 and were included based on their
v

presence in similar studies. There were a total of 13005 individuals aged 50 and older
who fit the criteria for this study. Separate Cox proportional hazards models were
created and ran to examine the association depressive symptom trajectories have on
modifying the effect multimorbidity has on all-cause and cancer mortality. Fine and Gray
models were created and ran to examine the association depressive symptom
trajectories have on modifying the effect multimorbidity has on cardiovascular disease
(CVD) mortality.
Results
From the final study population, 58.5% had persistently low depression symptoms,
24.9% had persistently moderate depression symptoms, and 16.6% had persistently
high depression symptoms. We found depressive symptom trajectories to significantly
modify the association between multimorbidity and cardiovascular mortality,
specifically among individuals who had three or more chronic conditions. The greatest
risk of cardiovascular death was among individuals who had three or more chronic
conditions and had persistently high depressive symptom trajectories (HR: 1.85; 95% CI:
1.22, 2.79). Depressive symptom trajectories did not significantly modify the association
between multimorbidity and all-cause or cancer mortality.
Conclusion
The findings from this study found that depressive symptom trajectories did not modify
the risk of all-cause or cancer-mortality in multimorbid individuals. Depressive symptom
trajectories did modify the association between multimorbidity and cardiovascular
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mortality. Findings from this study partially suggest that depressive symptom
trajectories may help to further stratify people who are at a higher risk for CVD
mortality. More studies need to be conducted to see if depressive symptom trajectories
modify the risk of death in all-cause and cancer-mortality when taking into account the
combination of diseases and the severity of the illness. Managing individuals with
persistent depressive symptoms and comorbid diseases should be explored to see if
properly managing these illnesses could mitigate the mortality effects seen.
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CHAPTER 1
INTRODUCTION
Middle-aged and older adults represent a sizable proportion of the U.S.
population with complex health care needs including higher utilization of health care
services, polypharmacy, frequent hospitalizations, and multimorbidity (Bodenheimer &
Berry-Millet, 2009). The prevalence of multimorbidity, the presence of two or more
conditions, ranges between 55% and 98% for middle-aged and older adults (Strauss et
al., 2014; Ward, 2010). High levels of multimorbidity are associated with an increased
risk of hospitalizations, deterioration of physical and cognitive health, higher medical
care expenditures, and death (Moran et al., 2015; Quiῆones et al., 2011; Violan et al.,
2014). Despite an accumulation of research examining multimorbidity and mortality, the
epidemiology and clinical course of multimorbidity remains poorly understood.
Depression is fairly common among middle-aged and older adults with multiple
chronic conditions (Rote, Chen, & Markides, 2015; Sinnige et al., 2013). Depression may
lead to increased social isolation, compound self-management by preventing one from
being adherent to medication and behavioral lifestyles (i.e., physical activity), and
activate the hypothalamic-pituitary-adrenal axis (HPA) which is associated with adverse
health outcomes (i.e., cardiovascular disease programming) (Barth, Schumacher, &
Herrmann-Lingen, 2004; van Dooren et al., 2013; Pinquart & Duberstein, 2010; Xiong &
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Zhang, 2013). The combination of multimorbidity and depression may lead to a
heightened vulnerability for death (Mezuk & Gallo, 2013). Several prior studies have
identified depression as a significant risk factor for all-cause mortality, cardiovascular,
cancer, and diabetic mortality (Barth, Schumacher, & Herrmann-Lingen, 2004; van
Dooren et al., 2013; Pinquart & Duberstein, 2010). ] However, the few studies reporting
a significant association between multimorbidity, depression, and mortality, examined
depression only at a single point in time. Depressive symptoms are dynamic (Gilsanz et
al., 2015). The course of depressive symptoms may vary over time, with fluctuating
severity or the remitting and relapsing nature of symptoms (Musliner et al., 2016).
Increasingly, longitudinal patterns of depressive symptoms (i.e. trajectories) are studied
in older adults (Andreescu et al., 2008; Byers et al., 2012; Hsu, 2012; Hybels et al., 2016;
Kuchibhatla et al., 2012; Kuo et al., 2011; Liang et al., 2011; Montagnier et al., 2014;).
However, little is known about the potential heterogeneity in the relationship between
multimorbidity and mortality by depression symptom trajectories.
Targeted and treating long-term depression among middle-aged and older adults
may provide an opportunity to reduce all-cause and cause-specific mortality. However,
our understanding of these mechanisms is limited and a more detailed study of the
relationship between multimorbidity, depressive symptoms trajectories, and mortality is
warranted. The overall objective of this study was to assess the longitudinal association
between multimorbidity and depressive trajectories on all-cause mortality among a
multi-ethnic community-dwelling sample of middle aged and older adults from 1998-
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2014, using data from the Health and Retirement Study (HRS). The following question
was explored:
Question 1: Do depressive symptom trajectories modify the association between
multimorbidity status and all-cause and cause-specific (cardiovascular and cancer)
mortality?
Hypothesis 1: It is hypothesized that high-risk depressive symptom trajectories
will be associated with an increased risk of all-cause mortality in comparison to low-risk
depressive symptom trajectories.
Hypothesis 2: It is hypothesized that high-risk depressive symptom
trajectories will be associated with cardiovascular and cancer mortality in comparison to
low-risk depressive symptom trajectories.
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CHAPTER 2
LITERATURE REVIEW
Multimorbidity
Multimorbidity is popularly defined as the co-existence of two or more chronic
conditions (Barnett et al., 2012; Fortin et al., 2004; Salive, 2013; Uijen & Lisdonk, 2008;
Van den Akker et al., 1998). The number of chronic conditions a person is diagnosed
with has been shown to increase with age (Barnett et al., 2012; Glynn et al., 2011;
Salive, 2013). Current multimorbidity prevalence is estimated to range from 65-98% in
older adult populations, those aged 65 and older (Glynn et al., 2011). In the United
States it is estimated that 81 million Americans will have more than two chronic
conditions by 2020 (Fortin et al., 2005).
Multimorbidity has been shown to be associated with a wide variety of adverse
health events including a decline in functional status, quality of life, and increasing
health care costs and utilization (Glynn et al., 2011; Marengoni et al., 2011; Salive,
2013). Studies from several different countries have found an increased risk of
functional decline or disability in regards to increasing numbers of chronic diseases
(Bayliss et al., 2004; Kadam & Croft, 2007; Loza et al., 2009; Marengoni et al., 2009;
Marengoni et al., 2011). For both longitudinal and cross-sectional studies participants’
functional status was ascertained by asking about necessary activities of daily living
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including questions regarding bathing, walking, dressing, eating, and using the toilet
(Bayliss et al., 2004; Kadam & Croft, 2007; Loza et al., 2009; Marengoni et al., 2009).
Some have hypothesized the clinical course, severity, and treatment type of these
conditions could affect the rate of decline in older adults (Bayliss et al., 2004; Marengoni
et al., 2009).
Multimorbidity has also been shown to have negative effects on quality of life.
The current literature shows an inverse association regarding the number of chronic
conditions one has and their quality of life (Byles et al., 2005; Chen, Baumgardner, &
Rice, 2007; Loza et al., 2009; Walker, 2007). Quality of life commonly incorporates a
person’s perceived physical, mental, and social well-being over time (Chen,
Baumgardner, & Rice, 2007). A person’s perceived health status and quality of life has
been documented to predict all-cause mortality, disease-specific morbidity, and
functional decline; therefore causing room for concern when dealing with patients who
have multiple chronic conditions (Bayliss, Ellis, & Steiner, 2007). An individual’s selfmanagement, self-care, and lack of a support system could hasten the decline of their
perceived quality of life (Bayliss, Ellis, & Steiner, 2007).
Health care costs and utilization is another consequence to having multiple
chronic conditions. The number of chronic conditions one has is strongly associated with
increased healthcare costs, number of medications, and hospital admissions (Condelius
et al., 2008; Glynn et al., 2011; Laux et al., 2008; Marengoni et al., 2011; Schneider,
O’Donnell, & Dean, 2009; Wolff, Starfield, & Anderson, 2002). A large study looking at
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Medicare recipients showed two thirds of the beneficiaries had multiple chronic
conditions yet accounted for 95% of the Medicare expenditures (Wolff, Starfield, &
Anderson, 2002). This spike in healthcare costs, medication prescriptions, and
admissions could be due to the complexity of care one receives as the number of
conditions increases (Schneider, O’Donnell, & Dean, 2009). Those who have multiple
diagnoses potentially receive contradictory advice from multiple physicians and receive
redundant services providing a challenge in managing these multiple ailments
(Schneider, O’Donnell, & Dean, 2009). These adverse health events associated with
multimorbidity highlight the burden those with multiple chronic conditions face.
Additionally, physicians have the problem of treating multiple conditions where one
medication could improve one chronic illness while worsening another.
In addition to having studies highlighting the consequences associated with
multimorbidity there is also well-documented literature on common chronic disease
conditions that are found together in individuals. One study recently conducted looked
at common dyads and triads of multiple chronic conditions across varying age groups
and found there were distinct clusters of conditions (Ward & Schiller, 2013). The two
most common dyads in both men and women aged 65 and older were ever having
hypertension and arthritis and ever having diabetes and hypertension (Ward & Schiller,
2013). In regards to the most common triads in men and women aged 65 and older ever
having arthritis, diabetes, and hypertension was the highest followed by ever having
arthritis, cancer, and hypertension (Ward & Schiller, 2013). While diabetes and
hypertension were found to be highly clustered with other diseases, depression was
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found to be the most commonly clustered ailment in a similar study (Sinnige et al.,
2013). Similarly this study also concluded hypertension, diabetes, and coronary artery
disease had a high prevalence of clustering among one another (Sinnige et al., 2013).
Finally, another study looked at patients who had Alzheimer’s disease and found
congestive heart failure, chronic obstructive pulmonary disease, diabetes, and cancer
were all clustered together (Vogeli et al., 2007). While these results show high rates of
hypertension and diabetes there are also stark differences. This gives room for more
research to be conducted in comorbid clustering but does give evidence to support the
high amounts of multimorbidity in populations.
Multimorbidity and Mortality in Older Adults
Increased healthcare costs, disability, and quality of life are all adverse health
effects of multimorbidity, however, the increased risk of mortality is also well
documented and of major concern. Many studies have shown that an increase in
multiple chronic conditions increases one’s risk of mortality, especially in older
populations (Gijsen et al., 2001; Loprinzi, Addoh, & Joyner, 2016; Marengoni et al., 2011;
Menotti et al., 2001; St John et al., 2014). The studies that examined the association
multimorbidity had on mortality were in a variety of locations and had varying follow up
times; however, the point remained that the presence of multimorbidity significantly
increased one’s risk of mortality (Gijsen et al., 2001; Loprinzi, Addoh, & Joyner, 2016;
Marengoni et al., 2011; Menotti et al., 2001; St John et al., 2014).
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Measuring Multimorbidity
While the literature is robust in the consequences multimorbidity is associated
with the measurement and classification of multimorbidity is not as well documented.
Multimorbidity is commonly measured through a simple disease count in individuals or
through weighted indices (Charleson Index, Elixhauser) that assess the burden of
morbidity over a broad range of conditions (Diederichs, Berger, & Bartels, 2011; Huntley
et al., 2012; Kadam & Croft, 2007). These popular methods come with their own
advantages and disadvantages. A basic disease count is the most common way to
measure multimorbidity and involves summing the number of conditions one has from
either self-reported, physician-reported, or medically recorded data (Huntley et al.,
2012). While data on disease counts and types of diseases is typically readily available it
is hard to compare between studies due to the varying number of conditions included
for analysis (Huntley et al., 2012). In recent systematic reviews the number of conditions
studied ranged from 4 to 102 different conditions (Diederichs, Berger, & Bartels, 2011;
Fortin et al., 2012; Harrison et al., 2014). Additionally, most disease counts are based on
summing up all chronic conditions but chronicity is seldom defined (Huntley et al.,
2012). Even among the multimorbidity literature there is a wide range of how
investigators group the number of conditions one has for analysis. For example, some
authors categorize multimorbidity as a binary outcome, no multimorbidity vs
multimorbidity (Bähler et al., 2015; Landi et al., 2010; Sharkey, 2003). However, others
classify multimorbidity according to varying disease counts; ranging from low
multimorbidity status (2-3 conditions) to high (6+ conditions) or to other
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predetermined, relevant disease count groups (Fung et al., 2008; Glynn et al., 2011;
Kadam & Croft, 2007; Menotti et al., 2001; St John et al., 2014). This heterogeneity in
disease count classification reinforces the limitation in using disease count data. This
study aims to capture specific populations who are at a higher risk of mortality based on
the number of chronic conditions they have.
Another common way to measure multimorbidity is through weighted indices
(Diederichs, Berger, & Bartels, 2011; Huntley et al., 2012). While there have been
several indices created to measure multimorbidity the “Charlson Index” is the most
frequently used (Diederichs, Berger, & Bartels, 2011). This index was created to use in
longitudinal studies to allow investigators to classify comorbid conditions in evaluating
prognoses, specifically mortality (Charlson et al., 1987; Diederichs, Berger, & Bartels,
2011; Huntley et al., 2012; Needham et al., 2005). This index provides a means for
investigators to assess the number of chronic conditions and their severity by looking at
the number of diseases a patient has multiplied by the relative mortality risk weight
(Charlson et al., 1987 Diederichs, Berger, & Bartels, 2011). For example, congestive
heart failure receives a mortality risk weight of one, whereas a metastatic solid tumor
receives a mortality risk weight of six (Needham et al., 2005). Since the time the
Charlson Index was first created there have been multiple versions created, differing in
the number of disease categories (Huntley et al., 2012). Since this measure has been
around for 30 years it has since been validated in an array of settings (Huntley et al.,
2012). Another advantage to using this index is it can be calculated from readily
available data (Huntley et al., 2012). However, in a recent systematic review it was
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found that simpler methods, such as disease counts, were just as predictive in mortality
and other healthcare outcomes (Huntley et al., 2012).
These two primary ways of classifying and measuring multimorbidity do an
adequate job at examining the association multimorbidity has on health outcomes,
however, more research is warranted to see if there are valid disease cut-points to be
used as well as the number of comorbid conditions to be included in the analysis.
Depression in Older Adults
The World Health Organization defined depression as a common mental disorder
which can be characterized by sadness, loss of interest or pleasure, feelings of guilt or
low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor
concentration (Depression). Major depressive disorder estimates vary for older adults,
aged 65 and older, with estimates ranging from 1-5% to 15-19% (Cahoon, 2012; Fiske,
Wetherell, & Gatz, 2009). However, the risks of a major depressive disorder have been
shown to increase with age; as older adults 75 and older have estimates between 5-9%
(Rodda, Walker, & Carter, 2011). While the estimates for major depressive disorder vary
there is a consensus of a higher prevalence of older adults who experience clinically
significant depressive symptoms, ranging from 5-37% (Fiske, Wetherell, & Gatz, 2009;
Rodda, Walker, & Carter, 2011). Additionally, these approximations were amplified
when looking at older adults who resided in long-term care facilities with a range of
having major depressive disorder or experiencing clinically relevant depressive
symptoms to be between 14-44% (Cahoon, 2012; Jones, Marcantonio, & Rabinowitz,
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2003; Teresi et al., 2001; Thakur & Blazer, 2008). However, these results could be
heightened by older adults who are undiagnosed or untreated (Barbour & Blumenthal,
2005; Barg et al., 2006; Rodda, Walker, & Carter, 2011). Depression recognition and
management is of utmost importance as the presence of depression increases ones risk
for morbidity, suicide, disability, and healthcare utilization while decreasing ones
physical, mental, and social functioning (Barbour & Blumenthal, 2005; Cahoon, 2012;
Fiske, Wetherell, & Gatz, 2009; Rodda, Walker, & Carter, 2011). A recent meta-analysiss
showed depression to be clustered with eight other diseases including hypertension,
arthritis, diabetes mellitus, chronic obstructive pulmonary disease (COPD)/asthma,
stroke, cancer, heart failure, and heart disease (Sinnige et al., 2013).
Depression and Mortality
Research has shown that depression and depressive symptoms can significantly
increase the risk of all-cause mortality for both men and women in older populations
(Cuijpers & Smit, 2002; Mykletun et al., 2009; Saz et al., 2001). One study even
controlled for a variety of behavioral and lifestyle risk factors that could mediate in the
association, however, they still saw mortality to be significantly increased by depression
by 37% (Mykletun et al., 2009).
According to the Centers for Disease Control and Prevention (CDC)
cardiovascular disease is the leading cause of death for both men and women, where
one in four deaths is from this disease (Heart Disease Facts, 2015). Cardiovascular
disease already has a high mortality rate but research has shown that depression
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increases this mortality rate (Barefoot et al., 1996; Barth, Schumacher, & HerrmannLingen, 2004; Frasure-Smith et al., 2009; Schulz et al., 2000). The range of mortality was
between 24-84%, with this showing an increase risk in mortality (Barefoot et al., 1996;
Barth, Schumacher, & Herrmann-Lingen, 2004; Frasure-Smith et al., 2009; Schulz et al.,
2000). Depression was also shown to elevate mortality risk in patients who had suffered
a myocardial infarction (Lespérance et al., 2002; Van Melle et al., 2004). Although the
mechanism for why depression and cardiovascular disease heighten one’s risk for
mortality there have been several plausible mechanisms proposed. One proposed
mechanism is the lifestyle which is commonly associated with depressed patients:
cigarette smokers, inactive, and hypertensive (Carney et al., 2002; Joynt, Whellan, &
O’Connor, 2003). These risk factors are known to increase one’s chances of being
diagnosed with cardiovascular disease. For example the relative risk of cardiovascular
mortality associated with smoking an additional pack of cigarettes a day increases by
39% (Joynt, Whellan, & O’Connor, 2003). An additional lifestyle factor hypothesized to
increase cardiovascular mortality risk is the act of noncompliance that is commonly seen
in depressed individuals (Carney et al., 2002; Joynt, Whellan, & O’Connor, 2003; Wang
et al., 2002). Wang and colleagues conducted a study looking at antihypertensive
medication use and found depressed individuals were more likely to be non-adherent
compared to their non-depressed counterparts (Wang et al., 2002). This lack of
compliance could play a significant role in cardiovascular mortality. There have also
been several proposed physiologic mechanisms examining the association between
depressive symptom trajectories and cardiovascular mortality.
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Cancer is the second leading cause of death in the United States and will affect
approximately 39% of men and women in their lifetime (Cancer Stat Facts: Cancer of any
Site, n.d.; Leading Causes of Death, 2017). Many studies and meta-analyses have
documented that depression significantly increased one’s cancer mortality risk (GieseDavis et al., 2010; Pinquart & Duberstein, 2010; Satin, Linden, & Phillips, 2009). In fact
one randomized controlled trial found that decreased depression symptoms was
associated with better survival compared to those with higher depression symptoms
(Giese-Davis et al., 2010). A meta-analysis showed cancer patients who experienced
depressed symptoms to have a 25% increased risk of mortality when looking at grouped
relative risks (Satin, Linden, & Phillips, 2009). Depression was also found to accelerate
disease progression in depressed cancer patients compared to non-depressed patients;
potentially being one of the reasons depressed individuals have increased mortality
rates (Sephton et al., 2009). They also found a stronger association of 39% in patients
who had a mild or major depressive diagnosis (Satin, Linden, & Phillips, 2009).
Additionally, depression is seen in cancer patients at higher rates compared to the
general population, with oropharyngeal, pancreatic, breast, and lung cancers seeing
higher rates of depression compared to other cancer types (Massie, 2002; Satin, Linden,
& Phillips, 2009). One proposed mechanism is the dysregulation of cortisol levels which
typically follow a circadian rhythm (Sephton et al., 2009; Spiegel & Giese-Davis, 2003;
Weinrib et al., 2010). Typically, negative feedback should be present during night hours,
however, in depressed individuals it has been shown not to be as active, causing the
cortisol levels to be abnormal (Sephton et al., 2009; Weinrib et al., 2010). This abnormal
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cortisol level has been shown to increase mortality risk and decrease functional
disability (Sephton et al., 2009; Weinrib et al., 2010).
Although depression is a debilitating disease on its own, it has also been
shown to be associated with a wide variety of morbidities and increased mortality rates.
Therefore, it is imperative to find ways to combat depression’s negative effects so
individuals are not losing precious time.
Depressive Symptom Trajectories
In studies where depression is involved there are two common ways of
measuring depression and its associated symptoms: a single baseline measurement or
trajectories of symptoms over a specified period of time. Popularly, depression status is
ascertained through a validated questionnaire where participants are commonly asked
how often they experience certain depressive symptoms (Rao & Cohen, 2004). The
Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale
(GDS), and Beck Depression Inventory (BDI) are common tools used to determine
depression status and symptoms in study subjects (Krebber et al., 2014; Rao & Cohen,
2004; Shafer, 2006). By summing the responses to the questions provided the analyst
can classify the participant based on predetermined cut-points for major, mild, some
depressive symptoms, and no depression. These depression scales have shown to have
both a sensitivity and specificity between 70-85%, strengthening the use of these
measures in studies (Rao & Cohen, 2004). By only using one single measurement of
depression, researchers are only able to gather information on a snapshot into the
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participants’ mental state. A single depression measurement does not allow researchers
to examine changes in depression status over time which could be an important factor
in describing the association at hand (Sin, Yaffe, & Whooley, 2015). Additionally, single
depression measurement does not capture intra-individual variability in symptoms
which may have clinical importance as older adults experience different depression
symptoms over time (Kaup et al., 2016). Finally, a single baseline measurement could
underestimate the risk of depression. For example, someone could live with persistently
high depression yet when they were surveyed their mood was positive; thus not
accurately presenting their true symptoms.
Utilizing depressive symptom trajectories is becoming more robust in the
literature (Gunn et al., 2013; Liang et al., 2011). Depression trajectories allow the
investigator the see temporal changes of depression symptoms which could reflect the
natural history of depression in the study population (Andreescu et al., 2008;
Kuchibhatla et al., 2012; Rote, Chen, & Markides, 2015). Additionally, depression
trajectories could be used to identify risk factors and certain outcomes associated with
varying trajectories (Hsu, 2012; Musliner et al., 2016). Depressive symptom trajectories
provide a more precise estimate over time and therefore allow for the identification of
high risk groups (Kaup et al., 2016). To create depression trajectories researchers utilize
the same tools (CES-D, GDS, BDI) used when only looking at baseline measurements of
depression (Andreescu et al., 2008; Hsu, 2012; Kuchibhatla et al., 2012; Rote, Chen, &
Markides, 2015). However, instead of collecting depression status at a single point in
time trajectory methods systematically gather depression status periodically for a
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specified period of time. After collecting this information latent growth curve analyses
can be performed to identify the varying trajectories (Byers et al., 2012; Liang et al.,
2013; Rote, Chen, & Markides, 2015). Although the use of depression trajectories has
many advantages it still has several limitations. One limitation is the trajectories are
dependent on the frequency of data collection involving depression status, and since
collection typically occurs annually or biannually there are still potential gaps left in
understanding the natural history (Rote, Chen, & Markides, 2015). Depression status is
typically determined through self-report, not a clinical diagnosis, and this self-reporting
could skew the trajectories slightly (Andreescu et al., 2008; Kuchibhatla et al., 2012).
However, the advantages of this method outweigh the limitations and should therefore
be used in research when looking at depression influences. The use of depressive
symptom trajectories can be more informative than a traditional, single measurement,
as depressive symptom trajectories can identify high risk groups. Upon identification of
high risk groups depression management programs can be targeted to treat these
individuals.
Depression Management among Multimorbid Individuals
Individuals who have depression coupled with multiple chronic conditions have
been shown to have more adverse health outcomes and increased mortality rates.
However, could depression management mitigate some of these negative outcomes?
Four randomized controlled trials found that depression management could reduce
adversary effects in multimorbid individuals, including a decrease in mortality rate
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(Bogner & de Vries, 2008; Gallo et al., 2016; Harrison et al., 2012; Katon et al., 2010).
Management programs included individual and group sessions aimed at educating the
individual on depression, chronic conditions, and healthy lifestyle factors (diet,
exercise), as well as collaborating with a medical team to come up with the best
medication regimen with ample follow-up time to provide information on the
individual’s progress and adherence to the program (Bogner & de Vries, 2008; Gallo et
al., 2016; Harrison et al., 2012; Katon et al., 2010). In the trials listed significant
reductions were seen in depressive symptoms, blood pressure readings, cholesterol
levels, mortality rates, and increased quality of life, and well-being (Bogner & de Vries,
2008; Gallo et al., 2016; Harrison et al., 2012; Katon et al., 2010). The results from these
randomized controlled trials show promising benefits in reducing adverse outcomes
depression can have on chronic diseases.
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CHAPTER 3
METHODS
Data Source:
The data is from the Health and Retirement Study which is a longitudinal biennial
survey of a nationally representative sample of U.S. adults aged 50 and older that
collects detailed information on physical health and functioning, cognition, disability,
socioeconomic factors, and health care expenditures. The Health and Retirement study
was sponsored by the National Institute of Aging and was conducted by the Institute of
for Social Research at the University of Michigan (Sonnega et al., 2014). Data collection
began in 1992 and is ongoing. The response rate was 81.4% in 1992 and was between
85% and 90% in the following waves (Heeringa & Connor, 1995; Juster & Suzeman,
1995, Sonnega et al., 2014). Detailed information concerning the sample design,
recruitment, response rates, and measurement validation are discussed extensively
elsewhere (Heeringa & Connor, 1995; Juster & Suzeman, 1995, Sonnega et al., 2014).
HRS provides sampling weights for the data sets and there is an oversampling of African
Americans and Hispanics, at about twice the rate of White respondents (Sonnega et al.,
2014).
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Study Population
This study used data from the Health and Retirement Study (HRS), primarily
utilizing the biennial waves from the years 1998, 2000, 2002, 2004, 2006, 2008, 2010,
2012, and 2014. The RAND files were utilized which are a cleaned and processed version
with consistent variable names (St Clair et al., 2002). Individuals were excluded if they
were younger than 50 years old or had missing information regarding the depression
symptom trajectories. Individuals who did not provide information on all eight chronic
disease statuses were also excluded from the analysis. 192 individuals were excluded
from the analysis because they were younger than 50. Additionally, 88 individuals were
excluded from the analysis because they did not provide responses on all of the eight
chronic diseases in question. After the exclusions of the 280 participants, the final
analytic study population was 13005.
Measurement of Variables
Exposure Variable
Multimorbidity was the main exposure for this study. Multimorbidity was
operationalized based on the self-report of eight chronic conditions. Chronic disease
status was collected based on self-report and ascertained by asking respondents, “Has a
doctor ever told you that you have high blood pressure or hypertension”. Eight chronic
conditions were used for analysis: high blood pressure, diabetes mellitus, cancer
(excluding cancer of the skin), lung disease, heart disease, stroke, psychiatric problems,
and arthritis. The total number of conditions was summed across all participants who
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indicated yes to a condition, giving a maximum score of eight chronic conditions. Similar
to prior studies, the number of chronic conditions was categorized as: 0, 1, 2, and 3+
(Menotti et al., 2001; Wong et al., 2008). When analyzing cancer, diabetes, and
cardiovascular mortality the groupings were 1, 2, and 3+ to account for the small sample
sizes in the groups.
Outcome Variable
All-cause mortality was the main outcome of interest for this study. Deaths
occurring from 2006-2014 were assessed and included in the analysis. Updates on vital
status were recorded at each biennial wave. If a death was reported, an exit interview
was conducted with the spouse or closest relative of the deceased to ascertain timing,
medical expenditures, and cause of death (Sonnega et al., 2014). Secondary outcomes
included cause-specific mortality outcomes: cardiovascular diseases, cancer, and
diabetes mellitus. All mortality outcomes will be assessed 2006-2014.
Cardiovascular and circulatory diseases were grouped using previously validated
administrative claims-based algorithms of International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) codes for chronic rheumatic heart diseases
(393-398), hypertensive diseases (401-405), ischemic heart diseases (410-414), diseases
of pulmonary circulation (415-417), other forms of heart disease (420-429),
cerebrovascular diseases (430-438), diseases of the arteries, arterioles, and capillaries
(440-448), and diseases of veins and lymphatics, and other diseases of the circulatory
system (451-459) (American Medical Association, 2004).
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Cancer was also be grouped using previously validated administrative claimsbased algorithms of ICD-9-CM codes for malignant neoplasms of lip, oral cavity, and
pharynx (140-149), malignant neoplasms of digestive organs and peritoneum (150-159),
malignant neoplasms of respiratory and intrathoracic organs (160-165), malignant
neoplasms of bone, connective tissue, skin, and breast (170-175), Kaposi’s Sarcoma
(176), malignant neoplasms of genitourinary organs (179-189), malignant neoplasms of
other and unspecified sites (190-199), and malignant neoplasms of lymphatic and
hematopoietic tissue (200-208) (American Medical Association, 2004).
As of 2010 these exit interviews, conducted by the Health and Retirement Study,
had been conducted for 93% of deceased participants (Sonnega et al., 2014). The death
records were verified through linkage between HRS data and the National Death Index
or the Social Security Death Index (Sonnega et al., 2014). The month and year of death
are recorded by the HRS to assign mortality status.
Effect Modifier
Depressive symptom trajectories were created prior to this analysis in able to
assess the hypothesis which suggested multimorbidity and all-cause mortality differed
depending on course of depressive symptoms. The depressive symptom trajectories
were created using HRS data from 1998-2004. The trajectories used in this analysis were
created using the depressive symptoms which were measured using an 8-item version
of the CES-D. HRS asked participants whether symptoms were experienced in the
previous week (yes or no) to the following questions: felt depressed; felt that everything
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I did was an effort; my sleep was restless; could not going; felt lonely; enjoyed life; felt
sad; and was happy. Positive items were reverse coded. HRS created a variable for the
summed depressive score for the participants. Reports of ≥3 symptoms were classified
as having elevated depressive symptoms. This dichotomization of depressive symptoms
threshold has been found to have high sensitivity and specificity and has been used in
prior studies (Mondesir et al., 2015). All participants who were missing more than four
items on the depressive scale were excluded from the analysis. The three trajectories
that were used in this analysis are those among older adults with persistently high,
persistently low depressive symptoms, persistently moderate depressive symptoms.
Confounders
In this analysis all confounders were assessed using the results from the 2004
wave of the Health and Retirement Study, prior to any mortality analysis. The
confounders used in this analysis have been previously identified in studies, thus
supporting them to be included in this study (Gallo et al., 2016, Lin et al., 2009, Loprinzi,
Addoh, & Joyner, 2016, Marengoni et al., 2009).
Sex was analyzed and categorized as “male” and “female”.
Age, in years, was analyzed using an HRS created variable. This already created
variable was collected and included in the analysis as a continuous variable.
Race and ethnicity was collected by asking two questions: “Do you consider
yourself primarily White or Caucasian, Black or African American, American Indian, or
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Asian, or something else” and “Do you consider yourself Hispanic or Latino”. Three
mutually exclusive categories were created to be used for this analysis: “Non-Hispanic
White”, “Non-Hispanic Black” and “Hispanic”.
Educational status was analyzed using a RAND created variable. This variable was
created by combining the years of schooling and highest degree earned in a more
general way. The RAND created categories were “less than high school”, “GED”, “high
school graduate”, “some college”, and “college and above”. “High school graduate”
included participants who reported 12 years of schooling exactly yet had no college
degree. Those who were grouped into “some college” reported a response showing
obtained a high school diploma or general educational development (GED) with more
than 12 years of schooling. Respondents who reported earning a college degree, of
Bachelor’s status or higher, were grouped in the category of “college and above”. For
analysis three education categories were created: less than a high school diploma, high
school diploma, and greater than a high school diploma.
Self-rated health was the participant’s self-reported general health status. The
possible answers to how a participant rated their general health status are: “excellent”,
“very good”, “good”, “fair”, and “poor”. For this analysis self-rated health was classified
into two categories: fair-poor and good-excellent.
Body Mass Index (BMI) was analyzed using a RAND created variable. This RAND
created variable took the respondent’s height, in feet and inches, and converted it to
meters. Likewise, the respondent’s weight, in pounds, was converted to kilograms. To
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calculate each participant’s BMI the respondent’s weight, now in kilograms, was divided
by their height in meters squared. The RAND created BMI was a continuous variable and
was analyzed as a continuous variable for this analysis.
Current smoking status was analyzed by asking participants if they currently
smoked cigarettes. Respondents answered “yes” if they were a current smoker and “no”
if they were not. For analysis these self-reported categories of “yes” and “no” will be
utilized.
Physical activity was obtained by asking participants three questions regarding
their vigorous, moderate, and mild levels of physical activity intensity. To ascertain
vigorous intensity physical activity, participants were asked, “How often do you take
part in sports or activities that are vigorous, such as running or jogging, swimming,
cycling, aerobics, or gym workout, tennis, or digging with a spade or shovel”. To gauge
participants moderate intensity physical activity, participants were asked, “How often
do you take part in sports or activities that are moderately energetic such as, gardening,
cleaning the car, walking at a moderate pace, dancing, and floor or stretching exercises”.
Finally, light intensity physical activity was ascertained by asking participants, “How
often do you take part in sports or activities that are mildly energetic, such as
vacuuming, laundry, and home repairs”. The response categories for each of the
physical activity questions were “hardly ever or never”, “1 to 3 times per month”, “once
per week”, “greater than once per week”, and “everyday”. Individual responses to the
questions were weighted by intensity using an average metabolic equivalent of task
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(MET) calculation (Latham & Williams, 2015). Intensity responses were multiplied by
their corresponding rates, 1.8 for vigorous, 1.4 for moderate, and 1.2 for light. The
scores were then summed for all three intensity levels of physical activity, which
produced a range from 0 to 17.6. The thresholds used to determine physical activity
intensity were: sedentary group (< 2.0); light intensity physical activity (>2.0 – 4.0);
moderate physical activity (>4.0 – 8.0); and vigorous physical activity (>8.0). These cut
points were based upon established MET thresholds (Latham & Williams, 2015).
Statistical Analysis
Descriptive statistics were reported for all parametric study variables by
multimorbidity grouping, with means and standard deviations calculated for continuous
variables and frequencies and percentages computed for categorical variables. Variables
that were nonparametric in nature were reported by multimorbidity grouping, with
medians for continuous variables. Bivariate analyses were conducted to determine
whether there were significant differences between multimorbidity classification and
determined covariates.
The association between multimorbidity and all-cause mortality and cancer
mortality were analyzed using Cox proportional hazards models. Cardiovascular
mortality and diabetes mortality were analyzed using Fine and Gray models to account
for any competing risks that could be present when analyzing these two causes of
deaths. A competing risk is present when an individual is at risk for more than one
mutually exclusive event, such as death from cardiovascular disease which will prevent
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death from any other cause (diabetes) from occurring (Gondara, 2015). These
competing risk models allowed for probabilities of death to be calculated even when
there were competing risks present (Gondara, 2015). Prior to running any Cox
proportional hazards models the proportionality assumption was tested to ensure this
method was best in examining the association of interest. Depressive symptom
trajectories were used to test the effect varying trajectories play on the three separate
outcomes in question. Separate models were created for each of the outcomes of
interest and included confounders based on prior studies concerning many of these
variables as confounders in the association between multimorbidity and all-cause
mortality (Landi et al., 2010, Loprinzi, Addoh, & Joyner, 2016, St John, Tyas, Menec, &
Tate, 2014). Four models were generated to model all-cause and cause-specific
mortality: Model 1 (Multimorbidity, survey year); Model 2 (Model 1 + age, sex, race,
education); Model 3 (Model 2 + BMI, self-rated health, smoking status, physical activity
level); and Model 4 (Model 3 + interaction term). A cross product term was included to
account for each potential interaction in the model. Two sided p-values ≤.05 were
considered statistically significant for all variables, including the interaction term.
Sampling weights were incorporated to account for the complex sampling
design. All the data management functions and statistical analyses were performed
using SAS version 9.4, Cary, NC, USA.
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Sensitivity Analysis
A sensitivity analysis was performed to assess the distribution of the data looking
at other chronic condition groupings, in comparison to the categorization proposed
above. When analyzing the literature, there were several different ways to
operationalize multimorbidity (Kleisiaris et al., 2016; Menotti et al., 2001; Villarreal et
al., 2015; Wong et al., 2008). Appendix A. shows the distribution of chronic conditions in
this population. This distribution coupled with the literature search helped determine
the best way to operationalize multimorbidity.
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CHAPTER 4
RESULTS
The distribution of multimorbidity is provided (Table 4.1). Nearly 33% of the study
population was diagnosed with three or more chronic conditions. Additionally, 28% of
the study population was diagnosed and living with 2 chronic conditions. Approximately
26% of the population had been diagnosed one chronic condition. Only 14% of the study
population had not been diagnosed with one of the eight chronic conditions in question.
The distribution of socio-demographic and lifestyle factors by multimorbidity
classification are listed in Table 4.2. The mean age for those individuals who had 0
chronic conditions was 66.1 years. As the number of conditions one was diagnosed with
increased so did the average age. The average age of study participants who had been
diagnosed with one chronic condition (68.3 years), two chronic conditions (70.1 years),
and three or more chronic conditions (71.7 years) was significantly older than those with
0 chronic conditions (p-value <.0001 for all multimorbidity groupings). Individuals
categorized as having 0 chronic conditions were more likely to be female (59.3%). The
percentage of females was statistically higher in individuals who had one (62.3%, pvalue .0293), and two chronic conditions (63.1, p-value .0057) compared to those with 0
chronic conditions. Individuals who had three or more chronic conditions saw an
increase in the percentage of women; however, this difference was not statistically
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significant when compared to individuals with 0 chronic conditions (61.9%, p-value
.0504). Among individuals who had 0 chronic conditions more than four fifths were
Whites (80.6%), less than one tenth were African American (9.0%), and one tenth were
Hispanic (10.4%). However, the racial demographic significantly differed as the number
of chronic conditions increased. The percentage of Whites decreased for individuals
with two and three or more chronic conditions (79.7%, 78.2%), yet increased slightly in
individuals with one chronic condition (81.6%). The percentage of Blacks increased for
individuals with one, two, or three or more chronic conditions (11.0%, 13.5%, and 15.3%
respectively). The Hispanic distribution decreased as the number of chronic conditions
increased (7.4%, 6.7%, and 6.4% respectively). This change in the racial makeup was
significantly different for all multimorbidity classifications. One chronic condition, two
chronic conditions, and three or more conditions had a statistically significant racial
distribution when compared to 0 chronic conditions (p-value .0002, p-value <.0001 and
p-value <.0001, respectively). The majority of individuals who had only 0 chronic
conditions had more than a high school diploma (49.8%) while one fifth of these
individuals had less than a high school diploma (19.9%). As the number of chronic
conditions increased so did the percentage of individuals who had less than a high
school diploma. For individuals who had one chronic condition, over one fifth had not
completed high school (20.9%), while 45.2% had more than a high school diploma. This
was a significantly different breakdown of education compared to those with 0 chronic
conditions (p-value .0060). Similarly, individuals who had two chronic conditions were
more likely to have less than a high school diploma (24.8%), while approximately two
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fifths had more than a high school diploma (40.1%). This breakdown was also
significantly different from the breakdown of individuals with 0 chronic conditions (pvalue <.0001). Approximately one third of the individuals who had three or more
chronic conditions had less than a high school diploma (34.6%), while one third had
more than a high school diploma (34.0%). This breakdown of educational attainment
was significantly different from the educational attainment of individuals with 0 chronic
conditions (p-value <.0001). More than four fifths (84.3%) of individuals who had 0
chronic conditions were non-smokers. Compared to individuals who had no chronic
conditions, those with one chronic condition, saw a statistically significant increase in
the percentage of non-smokers (87.0%, p-value .0075). Compared to individuals who
had no chronic conditions, those with two (88.7, p-value <.0001) or three or more
chronic conditions (87.4, p-value .0013), saw a statistically significant increase in the
percentage of non-smokers. Over nine tenths (92.5%) of the individuals who had 0
chronic condition rated their health as good, very good, or excellent. However, as the
number of chronic conditions increased the perception of ones’ self-rated health
decreased. Approximately 84.9% of individuals who had 1 chronic condition rated their
health as good, very good, or excellent, this being significantly different from those
individuals with 0 chronic conditions (p-value <.0001). Additionally, only about three
fourths (74.9%) of individuals who had two chronic conditions rated their health as
good, very good, or excellent; being statistically significant from those with 0-1 chronic
conditions (p-value <.0001). Only 51.3% of individuals who had three or more chronic
conditions rated their health as good, very good, or excellent. This was statistically
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different than the percentage of self-rated health for individuals with 0 chronic
conditions. Of the individuals who had 0 chronic conditions the majority engaged in
vigorous physical activity (51.6%), approximately one third engaged in moderate
intensity physical activity (36.4%), one tenth engaged in light intensity physical activity
(9.7%), and 2.30% were sedentary. There were significant changes seen in physical
activity levels as the number of chronic conditions increased to one, two, and three or
more chronic conditions (p-value <.0001, p-value <.0001, p-value <.0001, respectively).
Vigorous physical activity levels declined for those who had one, two, and three or more
chronic conditions (44.6%, 35.1%, and 23.8%, respectively). Moderate intensity physical
activity increased slightly among individuals who had one, two, and three or more
chronic conditions (39.3%, 40.7%, and 38.8%, respectively). Light intensity physical
activity saw increases in one, two, and three or more chronic conditions (11.3%, 16.9%,
and 21.7%, respectively). Levels of sedentary behavior also increased for one, two, and
three or more chronic conditions (4.9%, 7.3%, and 15.8%, respectively). Finally, the
average BMI level for individuals with 0 chronic conditions was 25.7. BMI levels, for one,
two, and three or more chronic conditions, saw significant increases (Averages: 26.6,
27.5, and 28.7; p-values: <.0001, respectively).
Figure 4.1 depicts the breakdown of all-cause, cardiovascular, and cancer,
mortality by multimorbidity grouping. Approximately 5.3% of the individuals who died
from cardiovascular disease had 0 chronic conditions. Individuals who had 1 chronic
condition saw 178 deaths, or approximately 13.2% of the total number of cardiovascular
deaths. This was statistically more deaths than those who had 0 chronic conditions (p-
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value .0333). Similarly, individuals who had two chronic conditions saw about one fourth
of the cardiovascular deaths (348 deaths, 25.8%). This was statistically more deaths than
those with 0 chronic conditions (p-value <.0001). The greatest number of cardiovascular
deaths occurred in individuals who had three or more chronic conditions (752 deaths,
55.74). This was statistically more deaths than those who had 0 chronic conditions (pvalue <.0001). Around one tenth (8.3%) of the individuals who died from cancer had 0
chronic conditions. Individuals who had one chronic condition saw 196 cancer deaths, or
19.9% of the total number of cancer deaths. Although a greater number of deaths
occurred, this was not statistically more deaths than those who had 0 chronic conditions
(p-value .2646). There were 269 cancer deaths, or 27.3%, to occur in individuals who
had two chronic conditions. This was statistically more cancer deaths compared to those
who had 0 chronic conditions (p-value .0234). Individuals who had four or more chronic
conditions and died from cancer had statistically more cases than those with 0 chronic
conditions (439 cases, 44.5%; p-value .0003).
Figure 4.2 displays the distribution of depression status by the number of chronic
conditions. There were significant changes seen in depression status as the number of
chronic conditions increased from 0 chronic conditions to one, two, and three or more
chronic conditions (p-value <.0001, p-value <.0001, p-value <.0001, respectively).
18.13% of those who had persistently low depression had 0 chronic conditions.
Persistently low depression levels increased from those with 0 chronic conditions to
those with one, two, and three or more chronic conditions (30.0%, 28.25%, and 23.7%,
respectively). 10.6% of the individuals with persistently moderate depression symptoms
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had 0 chronic conditions. Persistently moderate depression symptoms increased among
individuals who had one, two, and three or more chronic conditions (21.8%, 28.9%, and
38.7%, respectively). Individuals who had 0 chronic conditions made up approximately
5.1% of the population with persistently high depression symptoms. Persistently high
depression symptoms saw drastic increases in one, two, and three or more chronic
conditions (15.2%, 25.3%, and 54.4%, respectively).
Figure 4.3 graphically presents the interaction between depression trajectories
and multiple chronic conditions have on all-cause mortality. With 0 chronic conditions
being the reference group, it is shown that having persistently low depression scores
and one chronic condition has no increased risk for all-cause mortality (HR: 1.0; 95% CI:
0.8, 1.2). Having two or three or more chronic conditions coupled with persistently low
depression symptoms showed a slight increase in all-cause mortality, however, these
results did not reach statistical significance (HR: 1.0 and 1.17; 95% CI: 0.848, 1.210 and
0.980, 1.385, respectively). Having one or two chronic conditions coupled with
persistently moderate depression symptoms led to a slight increase in all-cause
mortality, however, these estimates did not reach statistical significance (HR: 1.146 and
1.186; 95% CI: 0.849, 1.548 and 0.895, 1.571, respectively). Similarly, having three or
more chronic conditions with persistently moderate depression pointed towards an
increased risk for all-cause, yet this did not reach statistical significance (HR: 1.287; 95%
CI: 0.981, 1.687). Having persistently high depression with multiple chronic conditions
did not show of an increased risk for all-cause mortality. Having one chronic condition
with persistently high depression scores only showed of a slight increase in the risk of
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mortality, but failed to reach significance (HR: 1.058; 95% CI: 0.692, 1.618). Two and
three or more chronic conditions with persistently high depression both showed an
increase in the estimate for all-cause mortality, but failed to reach statistical significance
(HR: 1.152 and 1.287; 95% CI: 0.775, 1.712 and 0.879, 1.885, respectively).
Figure 4.4 shows the adjusted associations of the interaction between
depression trajectories and having multiple chronic conditions on cancer mortality. With
one being the reference group, it is shown that having two or three or more chronic
conditions coupled with persistently low depression scores leads to a slight increase in
cancer mortality (HR: 1.072 and 1.094, respectively). However, both of these failed to
reach statistical significance (95% CI: 0.844, 1.361 and 0.868, 1.378, respectively).
Contrary to the results seen in persistently low depression scores, persistently moderate
depression scores led to a slight decrease in cancer mortality rates for both two and
three or more chronic conditions (HR: 0.945 and 0.836, respectively). These results
however failed to reach statistical significance (95% CI: 0.650, 1.375 and 0.592, 1.181,
respectively). Similarly, persistently high depression symptoms showed a slight decrease
in cancer mortality rates for both two and three or more chronic conditions (HR: 0.868
and 0.942, respectively). These results did not reach statistical significance (95% CI:
0.511, 1.472 and 0.591, 1.501, respectively).
Figure 4.5 shows the adjusted associations between the interaction between
depression trajectories and multiple chronic conditions on cardiovascular mortality.
Individuals who had two chronic conditions and persistently low depression symptoms
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saw an increase in cardiovascular mortality, however, this failed to reach significance
(HR: 1.230, 95% CI: 0.985, 1.537). Individuals who had three or more chronic conditions
and had persistently low depression symptoms saw a statistically significant increase in
cardiovascular mortality compared to those with only one chronic condition (HR: 1.486;
95% CI: 1.201, 1.839). Participants who had two chronic conditions and persistently
moderate depression symptoms saw an increase in cardiovascular death, but lacked
significance (HR: 1.416; 95% CI: 0.984, 2.038). Those with three or more chronic
conditions and had persistently moderate depression symptoms saw a statistically
significant increase in cardiovascular mortality compared to those who had one chronic
condition (HR: 1.758, 95% CI: 1.260, 2.453). Similar to previous multiple chronic
condition levels; individuals who had two chronic conditions with persistently high
depression symptoms saw an increased risk for cardiovascular mortality, but failed to
reach significance (HR: 1.223; 95% CI: 0.771, 1.940). Finally, individuals who had three or
more chronic conditions and persistently high depression symptoms saw a statistically
significant increase in cardiovascular mortality (HR: 1.847; 95% CI: 1.223, 2.789).
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Table 4.1: Distribution of multimorbidity classification

N

%

0 Chronic Conditions

1833

14.09

1 Chronic Condition

3319

25.52

2 Chronic Conditions

3623

27.86

3+ Chronic Conditions

4230

32.53

Total

13005

100.00
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Table 4.2: Baseline Characteristics by Multimorbidity Grouping: HRS 2004
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Age (mean, SD)
Gender
Male
Female
Race/Ethnicity
White
Black
Hispanic
Education
Less than HS
High School
More than HS
Self-Rated Health
Fair/Poor
Good/Excellent
Physical Activity
Sedentary
LIPA
MIPA
VIPA
BMI (mean, SD)

0 Chronic Conditions
N
%, SD
66.10
8.75
747
1086

40.75
59.25

1438
161
185

80.961
9.02
10.37

365
556
912

19.91
30.33
49.75

137
1696

7.47
92.53

42
177
666
943
25.73

2.30
9.68
36.43
51.59
4.43

1 Chronic Condition
N
%, SD P-Valuea
68.33 9.20
<.0001d
.0293
1250 37.66
2069 62.34
.0002
2658 81.61
359
11.02
240
7.37
.0060
695
20.94
1123 33.84
1501 45.22
<.0001
502
15.13
2816 84.87
<.0001
162
4.89
375
11.31
1301 39.25
1477 44.56
26.57 4.82
<.0001
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2 Chronic Conditions
N
%, SD P-Valueb
70.14 9.13
<.0001
.0057
1337 36.90
2286 63.10
<.0001
2850 79.72
484
13.54
241
6.74
<.0001
899
24.81
1271 35.08
1453 40.10
<.0001
909
25.11
2711 74.89
<.0001
263
7.27
613
16.93
1472 40.66
1272 35.14
27.52 5.36
<.0001

3+ Chronic Conditions
N
%, SD P-Valuec
71.69 9.24
<.0001
.0504
1611 38.09
2619 61.91
<.0001
3253 78.22
638
15.34
268
6.44
<.0001
1462 34.56
1331 31.47
1437 33.97
<.0001
2058 48.71
2167 51.29
<.0001
666
15.76
917
21.70
1638 38.76
1005 23.78
28.66 6.44
<.0001

a

p-value represents the comparison of variables in individuals with one chronic condition and those who reported 0 chronic
conditions
b
p-value represents the comparison of variables in individuals with two chronic conditions and those who reported 0 chronic
conditions
c
p-value represents the comparison of variables in individuals with three or more chronic conditions and those who reported 0
chronic conditions
d
bold font signifies a significant p-value
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Figure 4.1: Number of Deaths from All-Cause, Cardiovascular Disease, and Cancer by Multimorbidity Groupinga,b,c,d
a

p-value represents the comparison of variables between individuals who died and had one chronic condition and those who died
and had 0 chronic conditions
b
p-value represents the comparison of variables between individuals who died and had two chronic conditions and those who died
and had 0 chronic conditions
c
p-value represents the comparison of variables between individuals who died and had three or more chronic conditions and those
who died and had 0 chronic conditions
d
* signifies a significant p-value
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Figure 4.2: Depression Symptom Trajectories by Multimorbidity Classification
a

p-value represents the comparison of variables in individuals with one chronic condition and those who reported 0 chronic
conditions
b
p-value represents the comparison of variables in individuals with two chronic conditions and those who reported 0 chronic
conditions

40

c

p-value represents the comparison of variables in individuals with three or more chronic conditions and those who reported 0
chronic conditions
d
bold font signifies a significant p-value
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Figure 4.3: Interaction between Depressive Symptom Trajectories and Multimorbidity on All-Cause Mortality
a

: Adjusted for age, race, education, gender, self-rated health, smoking status, physical activity, and BMI
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Figure 4.4: Interaction between Depressive Symptom Trajectories and Multimorbidity on Cancer Mortality
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CHAPTER 5
DISCUSSION
This study was conducted to examine the association depressive symptom
trajectories coupled with multiple chronic conditions has on all-cause and cause-specific
mortality. Our results indicated having persistent depressive symptoms, along with
multiple chronic conditions, can cause an interaction, increasing one’s risk for mortality,
specifically cardiovascular mortality. Having three or more chronic conditions along with
persistently high depressive symptoms showed the highest risk of cardiovascular death.
This leads one to suggest that a dose-response association could be present; illustrated
by the greater number of chronic conditions one has along with persistently higher
depressive trajectory scores can lead to the greatest risk of death. Although a clear
association was seen in cardiovascular mortality, the association between depressive
symptom trajectories and multimorbidity on all-cause mortality was not as strong.
Cancer mortality also lacked significance, yet the direction of association was opposite
of that which was hypothesized.
Depressive Symptom Trajectories and Multimorbidity on All-Cause Mortality
Our results indicate the interaction between multimorbidity and persistent
depressive symptoms is not significant in predicting all-cause mortality. Although the
direction indicates a possible association between depressive symptom trajectories,
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multimorbidity, and all-cause mortality risk, these results did not reach statistical
significance. In a 2015 study conducted by Gallo and colleagues they analyzed depressed
and non-depressed patients with medical comorbidity to see if depressed patients had
an increased risk of all-cause mortality (Gallo et al., 2016). When looking at depressed
patients receiving usual care practices only those with the highest comorbidity saw a
significant increase in all-cause mortality, the lower levels of comorbidity did not reach
statistical significance (Gallo et al., 2016). This result is similar to what we saw in our
study, as the direction looked to be pointing to an association between depressive
symptom trajectories and multimorbidity on all-cause mortality, yet did not quite reach
statistical significance. The lack of significance here could be due to small sample sizes in
some of the groups being analyzed. Since the study at present just looked at the number
of conditions an individual has and not the combination of conditions one has, this could
be a reason for the lack of significance found.
Depressive Symptom Trajectories and Multimorbidity on Cancer Mortality
The results from our study indicate the interaction between depression
symptom trajectories and number of chronic conditions one has is not predictive for
cancer mortality. The direction of association for the interaction between depressive
symptom trajectories and multimorbidity on cancer mortality were slightly negative or
null. Current literature has shown that depression can cause an increase in mortality,
however, the role multimorbidity plays in this interaction is not as well understood
(Giese-Davis et al., 2010; Pinquart & Duberstein, 2010; Satin, Linden, & Phillips, 2009). A
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study aimed to analyze certain chronic conditions and depression (Gunn et al., 2012).
This study found after adjusted analyses that depression symptoms was not significantly
associated with cancer (Gunn et al., 2012). This leads one to hypothesize that
depression and multimorbidity might not be the driving factor for cancer mortality.
However, this study only looked at depression during a single measure, so having
additional studies analyzing depression symptom trajectories is warranted. Other
factors (treatment, stage, aggressiveness, type) could play a more decisive role in cancer
mortality than the interaction between depression symptom trajectories and
multimorbidity. In this current study we did not have information on stage,
aggressiveness, or type of cancer, which all could play a more critical role in cancer
mortality
Depressive Symptom Trajectories and Multimorbidity on Cardiovascular Mortality
The results from our study indicate the interaction between depressive symptom
trajectories and number of chronic conditions is predictive in cardiovascular mortality.
Regardless of persistent depression status, (low, moderate, high) individuals who had
three or more chronic conditions saw an increased risk of cardiovascular mortality.
However, those with persistently high depression symptom trajectories and three or
more chronic conditions saw the greatest risk for cardiovascular mortality (HR: 1.847;
95% CI: 1.223-2.789). These results are consistent with previous literature that showed
depression increased mortality risk in patients with cardiovascular disease (Barefoot et
al., 1996; Barth, Schumacher, & Herrmann-Lingen, 2004; Frasure-Smith et al., 2009;
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Penninx et al., 2001; Schulz et al., 2000). In a study among individuals who had
cardiovascular disease and major depression the risk of mortality was 3.0 times that of
non-depressed cardiovascular disease patients (Penninx et al., 2001). Our results
rereinforce the importance of prioritizing cardiovascular disease and depression
management, as the results are consistently pointing to an increased mortality risk. This
study shows the potential stratifying cardiovascular multimorbid patients by persistent
depression status can have in identifying high risk groups for targeted interventions.
Strengths and Limitations
This study has much strength, with one being the diverse, yet nationally
representative study population. Even with an oversampling of African Americans and
Hispanics the study population is still highly generalizable for the American population
(Sonnega et al., 2014). Additionally, this study analyzed depression using trajectory
methodology which allowed the investigators to see changes in depression symptoms
over time, reflecting the natural history of the disease (Andreescu et al., 2008;
Kuchibhatla et al., 2012; Rote, Chen, & Markides, 2015). This measurement method also
allowed the investigator to identify risk factors and certain outcomes with these
different trajectories (Hsu, 2012; Musliner et al., 2016). Analyzing how the interaction
between depressive symptom trajectories and multimorbidity affects cause-specific
mortality is a strength of this study. The literature on how depressive symptom
trajectories and multimorbidity affect cause-specific outcomes is lacking. Our study is
able to provide new light on how depressive symptom trajectories and multimorbidity
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affects cancer and cardiovascular mortality. Future studies should be conducted to see if
the associations seen here are replicated in varying populations. An additional strength
is the methodology involved with dealing with competing risks. Since cardiovascular
disease and diabetes are competing risks, due to the fact an individual is at risk for more
than one mutually exclusive event, using a model that accounted for these risks made
the results more reliable and valid (Gondara, 2015). Finally, this study had a clear
temporal order shown, as the exposure status was collected prior to the outcome.
Although this study had several strengths it also possesses several limitations.
Since this study used data from the HRS there is the possibility of recall bias; as some
participants might recall past illnesses differently than others. For example, someone
diagnosed with hypertension could potentially recall medical illnesses they have been
diagnosed with differently than someone without hypertension. A large study was
conducted in Canada comparing the agreement of self-report data to health
administrative data on seven chronic conditions: myocardial infarction, asthma,
diabetes, chronic lung disease, stroke, hypertension, and congestive heart failure
(Muggah et al., 2013). The researchers found good to very good agreement when
looking at diabetes and hypertension, moderate agreement for myocardial infarction
and asthma, and poor agreement for stroke, congestive heart failure, and COPD
(Muggah et al., 2013). In all cases the prevalence was higher in the health administrative
data except when looking at myocardial infarction and stroke (Muggah et al., 2013). This
shows that self-report data is a good tool at looking at some chronic conditions, yet it
does lack strength in other chronic conditions. There is also a possibility of information
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bias in this study. Depression has a negative stigma associated with it so individuals
might not have accurately reported feeling sad or other depressive like qualities.
Another limitation to this study is the lack of knowledge on disease severity and
treatment information. We do not know if individuals were properly managing their
illnesses, or if this would have affected our outcomes. Additionally, we did not adjust for
pharmacological or non-pharmacological information on depression treatments. There
was no available information on non-pharmacological treatment methods, and
pharmacological methods were only available for a sub-sample of the population.
Finally, covariates were not assessed as time-varying, so covariate status could have
changed. Although we did not assess confounders as time varying it is believed their effect
would be minimal as physical activity was one of our potential time varying confounders.
Physical activity intensity has been shown to decrease with age, so we believe the effects
potentially shown would have been minimal

Conclusions
It is well known and documented that having an increased number of chronic
conditions increases your likelihood of mortality. However, the effects depression,
coupled with having multiple chronic conditions, has on mortality is not as well
understood. This study found that the interaction between depression and multiple
chronic conditions can increase ones risk for cardiovascular and diabetes mortality. The
majority of the study population has more than one chronic condition, consistent with
the older American population, so it is imperative to properly manage and monitor
these individuals to help reduce the risk of mortality. Although it has been reported that
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depressed individuals are more likely to engage in poor management and lifestyle
choices (lack of medication adherence, more likely to smoke, sedentary lifestyle) a
randomized controlled trial reported the promising mortality benefits seen in
depressed, multimorbid patients after receiving chronic disease management (Gallo et
al., 2016). The mortality benefits seen in Gallo’s study, coupled with the affects seen in
this current study, highlight the importance chronic disease management could play in
treating patients with depression and multiple chronic conditions. Additional
management studies should be conducted to see if the effects are consistent when
looking at cause-specific mortalities.
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APPENDIX A-SENSITIVITY ANALYSIS
Table A.1: Distribution of the Number of Chronic Conditions

# of Conditions
0
1
2
3
4
5
6
7
8
Totals

N
1833
3319
3623
2374
1235
447
137
34
3
13005

72

%
14.09
25.52
27.86
18.25
9.50
3.44
1.05
0.26
0.02
100%

Table A.2: Distribution of Chronic Conditions by Depression Trajectories

Conditions
0
1
2
3
4
5
6
7
8
Totals

Low
(N, %)
1378, 10.60
2284, 17.56
2140, 16.46
1193, 9.17
485, 3.73
103, 0.79
17, 0.13
2, 0.02
0, 0.00
7602, 58.45

Moderate
(N, %)
344, 2.65
706, 5.43
936, 7.20
691, 5.31
378, 2.91
141, 1.08
40, 0.31
4, 0.03
0, 0.00
3240, 24.91

73

High
(N, %)
111, 0.85
329, 2.53
547, 4.21
490, 3.77
372, 2.86
203, 1.56
80, 0.62
28, 0.22
3, 0.02
2163, 16.63

Table A.3: Number of Chronic Conditions by Depression Status for All-Cause Mortality

Conditions

74

0
1
2
3
4
5
6
7
8
Totals

Low
1211, 13.52
1843, 20.58
1576, 17.60
752, 8.40
245, 2.74
40, 0.45
6, 0.07
1, 0.01
0, 0.00
2674, 63.36

No Death (N, %)
Moderate
282, 3.15
545, 6.09
631, 7.05
382, 4.27
168, 1.88
55, 0.61
16, 0.18
0, 0.00
0, 0.00
2079, 23.22

High
83, 0.93
235, 2.62
338, 3.77
276, 3.08
167, 1.86
67, 0.75
25, 0.28
11, 0.12
0, 0.00
1202, 13.42

74

Low
167, 4.12
441, 10.89
564, 13.93
441, 10.89
240, 5.93
63, 1.56
11, 0.27
1, 0.02
0, 0.00
1928, 47.60

Death (N, %)
Moderate
62, 1.53
161, 3.98
305, 7.53
309, 7.63
210, 5.19
86, 2.12
24, 0.59
4, 0.10
0, 0.00
1161, 28.67

High
28, 0.69
94, 2.32
209, 5.16
214, 5.28
205, 5.06
136, 3.36
55, 1.36
17, 0.42
3, 0.07
961, 23.73

Table A.4: Number of Chronic Conditions by Depression Status for Cancer Mortality

Conditions

75

0
1
2
3
4
5
6
7
8
Totals

Low
114, 3.72
312, 10.19
406, 13.26
333, 10.88
176, 5.75
49, 1.60
9, 0.29
1, 0.03
0, 0.00
890, 29.07

No Death (N, %)
Moderate
41, 1.34
115, 3.76
231, 7.54
243, 7.94
172, 5.62
66, 2.16
19, 0.62
3, 0.10
0, 0.00
1400, 45.72

High
20, 0.65
72, 2.35
171, 5.58
170, 5.55
165, 5.39
109, 3.56
49, 1.60
14, 0.46
2, 0.07
772, 25.21

75

Low
53, 5.38
128, 12.98
157, 15.92
108, 10.95
64, 6.49
14, 1.42
2, 0.20
0, 0.00
0, 0.00
526, 53.35

Death (N, %)
Moderate
21, 2.13
46, 4.67
74, 7.51
66, 6.69
38, 3.85
20, 2.03
5, 0.51
1, 0.10
0, 0.00
271, 27.48

High
8, 0.81
22, 2.23
38, 3.85
44, 4.46
40, 4.06
27, 2.74
6, 0.61
3, 0.30
1, 0.10
189, 19.17

Table A.5: Number of Chronic Conditions by Depression Status for CVD Mortality

Conditions

76

0
1
2
3
4
5
6
7
8
Totals

Low
1328, 11.51
2162, 18.75
1943, 16.85
1019, 8.84
387, 3.36
75, 0.65
14, 0.12
2, 0.02
0, 0.00
6930, 60.09

No Death (N, %)
Moderate
329, 2.85
666, 5.77
831, 7.21
573, 4.97
282, 2.45
94, 0.82
28, 0.24
3, 0.03
0, 0.00
2806, 24.33

High
103, 0.89
305, 2.64
476, 4.13
412, 3.57
279, 2.42
152, 1.32
52, 0.45
17, 0.15
1, 0.01
1797, 15.58

76

Low
48, 3.56
117, 8.67
187, 13.86
159, 11.79
83, 6.15
26, 1.93
3, 0.22
0, 0.00
0, 0.00
623, 46.18

Death (N, %)
Moderate
15, 1.11
38, 2.82
100, 7.41
108, 8.01
87, 6.45
40, 2.97
11, 0.82
1, 0.07
0, 0.00
400, 29.65

High
8, 0.59
23, 1.70
61, 4.52
70, 5.19
85, 6.30
42, 3.11
24, 1.78
11, 0.82
2, 0.15
326, 24.17

